Literature DB >> 16681172

Psychiatric disorders and their correlates among young adult MDMA users in Ohio.

Russel S Falck1, Robert G Carlson, Jichuan Wang, Harvey A Siegal.   

Abstract

This study describes the lifetime prevalence, correlates, and age of onset of selected psychiatric disorders among a community sample of MDMA users (n = 402), aged 18 to 30, in Ohio. Participants responded to interviewer-administered questionnaires, including sections of the computerized Diagnostic Interview Schedule for DSM-IV. Fifty-five percent of the sample had at least one lifetime disorder, with major depression (35.3%) and antisocial personality disorder (ASPD) (25.4%) the most common. Proportionately more women were diagnosed with depression, generalized anxiety disorder, and posttraumatic stress disorder (PTSD), while proportionately more men were diagnosed with ASPD. Proportionately more non-White participants had attention deficit/hyperactivity disorder (AD/HD). Higher levels of education were associated with proportionately less PTSD, ASPD, and AD/HD. Higher frequencies of MDMA use were associated with proportionately more ASPD and AD/HD. Comparing the age of first MDMA use with the age of onset for selected psychiatric disorders revealed that for most participants disorders preceded use. Multivariate analysis revealed participants with more than a high school education were less likely to have experienced a lifetime disorder, while those who had used MDMA more than 50 times were more likely. Variations in the prevalence of psychiatric disorders have practical implications for drug abuse prevention and treatment programs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16681172     DOI: 10.1080/02791072.2006.10399824

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  5 in total

1.  Ecstasy use and suicidal behavior among adolescents: findings from a national survey.

Authors:  Jueun Kim; Bin Fan; Xinhua Liu; Nancy Kerner; Ping Wu
Journal:  Suicide Life Threat Behav       Date:  2011-06-01

2.  MDMA (Ecstasy) use and psychiatric problems.

Authors:  Casey R Guillot; Mitchell E Berman
Journal:  Psychopharmacology (Berl)       Date:  2006-10-24       Impact factor: 4.530

Review 3.  3,4-methylenedioxymethamphetamine (MDMA): current perspectives.

Authors:  Jerrold S Meyer
Journal:  Subst Abuse Rehabil       Date:  2013-11-21

4.  Rare variant of lycanthropy and ecstasy.

Authors:  Mansoureh Nasirian; Nabi Banazadeh; Ali Kheradmand
Journal:  Addict Health       Date:  2009

5.  Self-reported PTSD is associated with increased use of MDMA in adolescents with substance use disorders.

Authors:  Lukas Andreas Basedow; Sören Kuitunen-Paul; Melina Felicitas Wiedmann; Veit Roessner; Yulia Golub
Journal:  Eur J Psychotraumatol       Date:  2021-09-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.